158 related articles for article (PubMed ID: 30811669)
1. Treatment of severe pediatric atopic dermatitis with methotrexate: A retrospective review.
Anderson K; Putterman E; Rogers RS; Patel D; Treat JR; Castelo-Soccio L
Pediatr Dermatol; 2019 May; 36(3):298-302. PubMed ID: 30811669
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.
Dvorakova V; O'Regan GM; Irvine AD
Pediatr Dermatol; 2017 Sep; 34(5):528-534. PubMed ID: 28730617
[TBL] [Abstract][Full Text] [Related]
3. The use of methotrexate for treating childhood atopic dermatitis: a multicenter retrospective study.
Taieb Y; Baum S; Ben Amitai D; Barzilai A; Greenberger S
J Dermatolog Treat; 2019 May; 30(3):240-244. PubMed ID: 30109960
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate for treatment of atopic dermatitis in children and adolescents.
Deo M; Yung A; Hill S; Rademaker M
Int J Dermatol; 2014 Aug; 53(8):1037-41. PubMed ID: 24602088
[TBL] [Abstract][Full Text] [Related]
5. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study.
Shah N; Alhusayen R; Walsh S; Shear NH
J Cutan Med Surg; 2018; 22(5):484-487. PubMed ID: 29855201
[TBL] [Abstract][Full Text] [Related]
7. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.
El-Khalawany MA; Hassan H; Shaaban D; Ghonaim N; Eassa B
Eur J Pediatr; 2013 Mar; 172(3):351-6. PubMed ID: 23229188
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
11. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
[TBL] [Abstract][Full Text] [Related]
12. The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children.
Rahman SI; Siegfried E; Flanagan KH; Armbrecht ES
J Am Acad Dermatol; 2014 Feb; 70(2):252-6. PubMed ID: 24332314
[TBL] [Abstract][Full Text] [Related]
13. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate for the treatment of adult atopic dermatitis.
Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
[TBL] [Abstract][Full Text] [Related]
15. Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
Védie AL; Ezzedine K; Amazan E; Boralevi F; Milpied B; Taïeb A; Seneschal J
Acta Derm Venereol; 2016 Aug; 96(6):802-6. PubMed ID: 26925822
[TBL] [Abstract][Full Text] [Related]
16. Long-term off-label dupilumab in pediatric atopic dermatitis: A case series.
Treister AD; Lio PA
Pediatr Dermatol; 2019 Jan; 36(1):85-88. PubMed ID: 30338546
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of methotrexate for childhood atopic dermatitis.
Purvis D; Lee M; Agnew K; Birchall N; Dalziel SR
J Paediatr Child Health; 2019 Dec; 55(12):1487-1491. PubMed ID: 31016803
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
19. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
